This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Rhabdomyoma
Information about Rhabdomyoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Rhabdomyoma
Most recent studies have shown that Rhabdomyoma shares some biological mechanisms with benign-neoplasm, cardiac-arrhythmia, cardiac-rhabdomyoma, fetal-diseases, fibroma, hamartoma, head-and-neck-neoplasms, heart-failure, heart-neoplasm, hemangioma, lipoma, malignant-paraganglionic-neoplasm, myxoma, neoplasms, rhabdomyosarcoma, sarcoma, sclerosis, teratoma, tuberous-sclerosis.
Among the many pathways, these few ones have gauged particular interests from scientists studying Rhabdomyoma, and have been seen in publications frequently: Cardiac Conduction, Cell Death, Cell Growth, Cell Proliferation, Coagulation, Enucleation, Interphase, Localization, Lung Morphogenesis, Mitosis, Muscle Cell Proliferation, Ossification, Pathogenesis, Peroxidase Reaction, Phagocytosis, Programmed Cell Death, Reflex, Transdifferentiation, Transposition
Quite a number of genes have been found to play important roles in Rhabdomyoma, such as CACNA1C, CD68, DES, ENO2, GFAP, MB, MTOR, MUC1, MYH14, MYOG, S100A1, S100B, SLC12A3, TBXAS1, TESC, TSC1, TSC2, TYMS, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.